Yap1-Scribble polarization is required for hematopoietic stem cell division and fate.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
15 10 2020
Historique:
received: 14 11 2019
accepted: 13 05 2020
pubmed: 3 6 2020
medline: 16 6 2021
entrez: 3 6 2020
Statut: ppublish

Résumé

Yap1 and its paralogue Taz largely control epithelial tissue growth. We have identified that hematopoietic stem cell (HSC) fitness response to stress depends on Yap1 and Taz. Deletion of Yap1 and Taz induces a loss of HSC quiescence, symmetric self-renewal ability, and renders HSC more vulnerable to serial myeloablative 5-fluorouracil treatment. This effect depends on the predominant cytosolic polarization of Yap1 through a PDZ domain-mediated interaction with the scaffold Scribble. Scribble and Yap1 coordinate to control cytoplasmic Cdc42 activity and HSC fate determination in vivo. Deletion of Scribble disrupts Yap1 copolarization with Cdc42 and decreases Cdc42 activity, resulting in increased self-renewing HSC with competitive reconstitution advantages. These data suggest that Scribble/Yap1 copolarization is indispensable for Cdc42-dependent activity on HSC asymmetric division and fate. The combined loss of Scribble, Yap1, and Taz results in transcriptional upregulation of Rac-specific guanine nucleotide exchange factors, Rac activation, and HSC fitness restoration. Scribble links Cdc42 and the cytosolic functions of the Hippo signaling cascade in HSC fate determination.

Identifiants

pubmed: 32483624
pii: S0006-4971(20)61632-9
doi: 10.1182/blood.2019004113
pmc: PMC7568035
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Biomarkers 0
Membrane Proteins 0
SCRIB protein, human 0
Transcription Factors 0
Tumor Suppressor Proteins 0
YAP-Signaling Proteins 0
YAP1 protein, human 0
CDC42 protein, human EC 3.6.5.2
cdc42 GTP-Binding Protein EC 3.6.5.2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1824-1836

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK108743
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY032029
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA030199
Pays : United States
Organisme : NHLBI NIH HHS
ID : F31 HL132468
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA193350
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA192642
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA218254
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL147536
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK104814
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL132211
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA211794
Pays : United States

Informations de copyright

© 2020 by The American Society of Hematology.

Références

Nat Commun. 2019 Jan 4;10(1):46
pubmed: 30610188
Nature. 2011 Jun 08;474(7350):179-83
pubmed: 21654799
Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1248-53
pubmed: 17227869
J Exp Med. 2000 Nov 6;192(9):1273-80
pubmed: 11067876
J Exp Clin Cancer Res. 2017 Oct 10;36(1):139
pubmed: 29017577
Cell Stem Cell. 2012 May 4;10(5):520-30
pubmed: 22560076
Nat Cell Biol. 2020 Apr;22(4):498-511
pubmed: 32203420
J Immunol. 2007 Jun 1;178(11):6746-51
pubmed: 17513721
J Exp Med. 2000 Nov 6;192(9):1281-8
pubmed: 11067877
Nat Immunol. 2013 Jul;14(7):756-63
pubmed: 23708252
Leukemia. 2018 Sep;32(9):2037-2040
pubmed: 29654273
EMBO J. 2012 Mar 7;31(5):1109-22
pubmed: 22234184
J Exp Med. 2014 May 5;211(5):769-79
pubmed: 24752302
Curr Biol. 2004 Jun 8;14(11):987-95
pubmed: 15182672
Sci Rep. 2017 Feb 07;7:42125
pubmed: 28169360
Cell Stem Cell. 2017 Jul 6;21(1):91-106.e6
pubmed: 28457749
Blood. 1984 Aug;64(2):393-9
pubmed: 6743824
Immunity. 2004 Feb;20(2):153-65
pubmed: 14975238
Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5465-70
pubmed: 20304793
PLoS One. 2012;7(2):e32013
pubmed: 22363786
Science. 2003 Oct 17;302(5644):445-9
pubmed: 14564009
PLoS Biol. 2018 Sep 20;16(9):e2003389
pubmed: 30235201
Nat Med. 2005 Aug;11(8):886-91
pubmed: 16025125
J Clin Invest. 2015 Jan;125(1):177-82
pubmed: 25415437
J Exp Med. 2011 Dec 19;208(13):2691-703
pubmed: 22110168
Cell. 2011 Nov 11;147(4):759-72
pubmed: 22078877
Cell. 2008 Dec 12;135(6):1118-29
pubmed: 19062086
Dev Cell. 2016 Mar 7;36(5):572-87
pubmed: 26923725
J Exp Med. 2017 Jan;214(1):165-181
pubmed: 27998927
Leukemia. 2018 May;32(5):1211-1221
pubmed: 29467485
Nature. 2009 Apr 16;458(7240):904-8
pubmed: 19212321
PLoS Biol. 2013;11(8):e1001620
pubmed: 23940457
Dev Cell. 2016 Jun 6;37(5):399-412
pubmed: 27237790
Blood. 2005 Mar 15;105(6):2340-2
pubmed: 15550486
Stem Cells. 2005 Mar;23(3):335-46
pubmed: 15749928
J Biol Chem. 2017 Dec 15;292(50):20425-20436
pubmed: 29061852
Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):10918-10923
pubmed: 28973878
Nat Commun. 2017 Feb 08;8:14382
pubmed: 28176763
J Cell Biol. 2019 Mar 4;218(3):742-756
pubmed: 30598480
Blood. 2008 Apr 1;111(7):3313-21
pubmed: 18083846
Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9957-62
pubmed: 21653884
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5091-6
pubmed: 17360364
J Genet Genomics. 2011 Oct 20;38(10):461-70
pubmed: 22035867
Nat Genet. 2014 Mar;46(3):245-52
pubmed: 24487275
Cell Stem Cell. 2007 Nov;1(5):541-54
pubmed: 18345353
Dev Cell. 2020 Feb 24;52(4):446-460.e5
pubmed: 32032546
Cell Rep. 2015 Feb 10;10(5):740-754
pubmed: 25660024
Nat Cell Biol. 2014 Jan;16(1):108-17
pubmed: 24362629
Mol Syst Biol. 2018 Aug 20;14(8):e8129
pubmed: 30126976
Nat Med. 2015 Nov;21(11):1307-17
pubmed: 26457757
Genes Dev. 2007 Nov 1;21(21):2747-61
pubmed: 17974916
Blood. 2012 Mar 15;119(11):2510-22
pubmed: 22174158
Cell. 2003 Aug 22;114(4):445-56
pubmed: 12941273
PLoS Biol. 2007 Aug;5(8):e201
pubmed: 17676974
Dev Cell. 2010 Feb 16;18(2):309-16
pubmed: 20159600
J Mol Biol. 2018 Sep 28;430(19):3585-3612
pubmed: 29409995
Proc Natl Acad Sci U S A. 2009 May 26;106(21):8579-84
pubmed: 19439659
Nature. 2013 Nov 21;503(7476):392-6
pubmed: 24141946
Cell. 2005 Aug 12;122(3):421-34
pubmed: 16096061
J Exp Med. 2013 Jan 14;210(1):15-22
pubmed: 23277453
Dev Cell. 2010 Apr 20;18(4):579-91
pubmed: 20412773
Cell Rep. 2019 Aug 13;28(7):1703-1716.e6
pubmed: 31412241
Science. 2000 Mar 10;287(5459):1804-8
pubmed: 10710306

Auteurs

Mark J Althoff (MJ)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Hoxworth Blood Center, University of Cincinnati Academic Health Center, Cincinnati, OH.
Cancer & Cell Biology Program, University of Cincinnati College of Medicine, Cincinnati, OH; and.

Ramesh C Nayak (RC)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Hoxworth Blood Center, University of Cincinnati Academic Health Center, Cincinnati, OH.

Shailaja Hegde (S)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Hoxworth Blood Center, University of Cincinnati Academic Health Center, Cincinnati, OH.

Ashley M Wellendorf (AM)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Breanna Bohan (B)

Hoxworth Blood Center, University of Cincinnati Academic Health Center, Cincinnati, OH.

Marie-Dominique Filippi (MD)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Cancer & Cell Biology Program, University of Cincinnati College of Medicine, Cincinnati, OH; and.

Mei Xin (M)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Q Richard Lu (QR)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Hartmut Geiger (H)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Yi Zheng (Y)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Maria T Diaz-Meco (MT)

Sanford-Burnham-Prebys Discovery Cancer Institute, La Jolla, CA.

Jorge Moscat (J)

Sanford-Burnham-Prebys Discovery Cancer Institute, La Jolla, CA.

Jose A Cancelas (JA)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Hoxworth Blood Center, University of Cincinnati Academic Health Center, Cincinnati, OH.
Cancer & Cell Biology Program, University of Cincinnati College of Medicine, Cincinnati, OH; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH